Botulinum toxin type A
Contents
Description
Botulinum toxin type A is a neurotoxin that temporarily paralyzes muscles by blocking acetylcholine release at neuromuscular junctions. It is used off-label for facial myokymia and other movement disorders involving involuntary muscle contractions. The therapeutic effect typically lasts 3-6 months, requiring repeat injections.
Indications & Therapeutic Use
chronic migraine, cervical dystonia, blepharospasm, strabismus, facial myokymia, hyperhidrosis, overactive bladder
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Botulinum toxin type A — GNH India
132 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | botulinum toxin type A |
| Brands | 1 brand available |
| Active Ingredient | onabotulinumtoxinA |
| Drug Class | chronic migraine |
| Manufacturer | Allergan (AbbVie) |
| Dosage Forms | powder for injection 50 units, 100 units, 200 units per vial |
| Medical Code | M03AX01 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |